 "Claris Lifesciences denies talks to sell injectables arm")
Generic drugmaker Claris Lifesciences Ltd said on Thursday it was not in talks to sell its stake in injectable drugs business, and has not considered such an action.
The company issued the statement in response to a report in the Economic Times that said several large pharmaceutical companies were in a race to buy Claris's sterile injectables business.
Claris said it had "neither considered not taken any decision in this regard."
The company's shares rose as much as 20% to Rs 248.20 on Thursday, while the broader NSE index was up 0.64%.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app